Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1164)	12/20/1997 6:28:00 AM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

The Zonagen (ZONA)/Texas Biotech (TXB) circle jerk. I now turn your attention to the well-organized, and professional-looking web page of biotech superstar Zonagen: zonagen.com Read it carefully, particularly the section about products under development. Is this a company you would pay $260 million for? Note that David McWilliams, president of a bizarre, worthless company called Texas Biotechnology Corporation (TXB), sits on Zonagen's board. It is extremely interesting to note that TXB's capitalization structure has amazing parallels to Zonagen. Just like Zonagen's fortuitous deal with Scering-plough, TXB also has a licensing deal with a reputable firm - SmithKline, who also happens to be an early investor. sec.yahoo.com We all know that fine companies like ZONA and TXB are more concerned with advancing modern medicine than lining their pockets. We can rest assured that they wouldn't resort to dealing with Wall Street bottom feeders......right? worth.com